Status:
UNKNOWN
NHFOV vs NIPPV vs nCPAP in Preterm Infants With Respiratory Distress Syndrome
Lead Sponsor:
Jiulongpo No.1 People's Hospital
Conditions:
Preterm Infant
Eligibility:
All Genders
Up to 12 years
Phase:
NA
Brief Summary
This will be a prospective, multi-center, three-arms,parallel, randomized, controlled trial with a superiority design,conducted in China. The investigators conduct this multi-centre, randomized, contr...
Detailed Description
Preterm infants are eligible to the study if they they match the following inclusion criteria: (1) Gestational age (GA) less than 30 weeks or Birth weight less than 1500g; (2) They have a diagnose of ...
Eligibility Criteria
Inclusion
- Gestational age (GA) of less than 30 weeks or birth weight less than 1500g
- Clinical diagnose of RDS
- Parental consent
Exclusion
- Intubated for resuscitation or for other reasons at birth
- Major congenital malformations or known complex congenital heart disease
- No parental consent
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 21 2022
Estimated Enrollment :
684 Patients enrolled
Trial Details
Trial ID
NCT03842462
Start Date
November 1 2020
End Date
May 21 2022
Last Update
November 18 2020
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400042
2
Chongqing Women and Children Health Hospital
Chongqing, Chongqing Municipality, China, 401120
3
Chongqing Three Gorges Central Hospital
Chongqing, Chongqing Municipality, China, 404100
4
Guiyang Maternity and Child Health Care Hospital
Guiyang, Guizhou, China, 550000